Research output per year
Research output per year
- 1 - 50 out of 118 results
Search results
-
2024
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
Fehniger, T. A., Watkins, M. P., Ezenwajiaku, N., Wan, F., Hurd, D. D., Cashen, A. F., Blum, K. A., Goy, A., Fenske, T. S., Wagner-Johnston, N. D., Carson, K., Siegel, M. J., Russler-Germain, D., Schneider, S. E., Mehta-Shah, N., Kahl, B. & Bartlett, N. L., Mar 2024, In: Haematologica. 109, 3, p. 953-957 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease
Pusic, I., Lee, C., Veeraputhiran, M., Minor, C. & DiPersio, J. F., Feb 2024, In: Bone Marrow Transplantation. 59, 2, p. 282-284 3 p.Research output: Contribution to journal › Letter › peer-review
3 Scopus citations -
False-positive human immunodeficiency virus nuclear acid amplification technique testing following therapy with transgenic T cell receptor cellular therapy for synovial sarcoma
Slade, M., Araujo, D., Du, M., Parikh, B., Anderson, N., Van Tine, B. A. & Ghobadi, A., 2024, (Accepted/In press) In: Bone Marrow Transplantation.Research output: Contribution to journal › Letter › peer-review
-
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model
Archer, K. J., Fu, H., Mrózek, K., Nicolet, D., Mims, A. S., Uy, G. L., Stock, W., Byrd, J. C., Hiddemann, W., Braess, J., Spiekermann, K., Metzeler, K. H., Herold, T. & Eisfeld, A. K., Dec 2024, In: Journal of Hematology and Oncology. 17, 1, 28.Research output: Contribution to journal › Letter › peer-review
Open Access -
Molecular responses in decitabine-and decitabine/venetoclax-Treated patients with acute myeloid leukemia and myelodysplastic syndromes
Gruszczynska, A., Maiti, A., Miller, C. A., Ramakrishnan, S. M., Link, D. C., Uy, G. L., Petti, A. A., Hayes, K., Nardo, C. D. D., Ravandi, F., Ley, T. J., Spencer, D. H., Gao, F., Konopleva, M. Y. & Welch, J. S., 2024, In: Haematologica.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization
Cancilla, D., Rettig, M. P., Karpova, D., Thakellapalli, H., Singh, M., Meyers, M. J., Ruminski, P. G., Christ, S., Chendamarai, E., Gao, F., Gehrs, L., Ritchey, J. K., Prinsen, M. & DiPersio, J. F., Mar 26 2024, In: Blood Advances. 8, 6, p. 1379-1383 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access3 Scopus citations -
The Association of Agent Orange Exposure with the progression of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based study of Vietnam War Era Veterans
Liu, L. W., Wang, M., Grandhi, N., Schroeder, M. A., Thomas, T., Vargo, K., Gao, F., Sanfilippo, K. M. & Chang, S. H., Dec 2024, In: Journal of Hematology and Oncology. 17, 1, 3.Research output: Contribution to journal › Letter › peer-review
Open Access -
2023
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002
Meyers, G., Hamadani, M., Martens, M., Ali, H., Chevallier, P., Choe, H., Harris, A. C., Holler, E., van Hooren, E., Klaassen, W., Leifer, E., van Oosterhout, Y., Perez, L., Pusic, I., Stelljes, M., van der Velden, W., Ammatuna, E., Beauvais, D., Cornillon, J. & Maziarz, R. T. & 5 others, , Dec 2023, In: Bone Marrow Transplantation. 58, 12, p. 1416-1418 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
A randomized phase II/III study of ‘novel therapeutics’ versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612
Assouline, S., Michaelis, L. C., Othus, M., Hay, A. E., Walter, R. B., Jacoby, M. A., Schroeder, M. A., Uy, G. L., Law, L. Y., Cheema, F., Sweet, K. L., Asch, A. S., Liu, J., Moseley, A. B., Maher, T., Kingsbury, L. L., Fang, M., Radich, J., Little, R. F. & Erba, H. P., 2023, In: Leukemia and Lymphoma. 64, 2, p. 473-477 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access4 Scopus citations -
Association of social deprivation with survival in younger adult patients with AML: an Alliance study
Rebechi, M., Kohlschmidt, J., Mrózek, K., Nicolet, D., Mims, A. S., Blachly, J. S., Orwick, S., Larkin, K. T., Oakes, C. C., Hantel, A., Carroll, A. J., Blum, W. G., Powell, B. L., Uy, G. L., Stone, R. M., Larson, R. A., Byrd, J. C., Paskett, E. D., Plascak, J. J. & Eisfeld, A. K., Aug 8 2023, In: Blood Advances. 7, 15, p. 4019-4023 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access5 Scopus citations -
Clonal hematopoiesis in survivors of childhood cancer
Friedman, D. N., Chan, I. C. C., Moskowitz, C. S., Li, S., Turner, K., Liu, J., Bouvier, N., Walsh, M. F., Spitzer, B., Kung, A. L., Berger, M., Cooper, M. A., Pusic, I., Uy, G., Link, D., Druley, T. E., Diaz, L. A., Levine, R. L., Shukla, N. & Bolton, K. L., Aug 8 2023, In: Blood Advances. 7, 15, p. 4102-4106 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access9 Scopus citations -
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study
Bhatnagar, B., Kohlschmidt, J., Orwick, S. J., Buelow, D. R., Fobare, S., Oakes, C. C., Kolitz, J. E., Uy, G., Stock, W., Powell, B. L., Nicolet, D., Hertlein, E. K., Mrózek, K., Blachly, J. S., Eisfeld, A. K., Baker, S. D. & Byrd, J. C., Aug 16 2023, In: Blood Advances. 7, 16, p. 4671-4675 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
Idiopathic multicentric Castleman disease in an adolescent diagnosed following COVID-19 infection
Mosleh, E., Mehta, S., Young, E., Zhang, L., Vij, K. & Schuettpelz, L. G., Jun 2023, In: Pediatric Blood and Cancer. 70, 6, e30239.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
Measuring Financial Toxicity: A Closer Look
LeBlanc, M. R., Coles, T., Biddell, C. B. & Fiala, M. A., Jun 2023, In: Value in Health. 26, 6, p. 953-955 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Overexpression of S100A9 in donor T cells is associated with reconstitution of gut microbiota and outcome of allogeneic hematopoietic stem cell transplantation
Kim, S., Lim, S., Razmkhah, F. & Choi, J., Jun 2023, In: Blood Research. 58, 2, p. 105-111 7 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Patient portal recruitment may exacerbate underrepresentation in clinical trial participants
Fiala, M. A., Sep 2023, In: Journal of the American Geriatrics Society. 71, 9, p. 2998-2999 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Socioeconomic marginalization and health outcomes in newly diagnosed multiple myeloma: A population-based cohort study
Visram, A., Seow, H., Fiala, M. A., Gayowsky, A., Cheung, M., Davies, G., Pond, G. R. & Mian, H., Aug 2023, In: American journal of hematology. 98, 8, p. E197-E199Research output: Contribution to journal › Letter › peer-review
Open Access -
Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia
Afzal, A., Fiala, M. A., Jacoby, M. A. & Walter, M. J., Aug 8 2023, In: Blood Advances. 7, 15, p. 3838-3841 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Use of the Current Standard of Practice Serum Free Light Chains (sFLC) Reference Interval Puts Black Patients at 5 Times Higher Odds for Light Chain Monoclonal Gammopathy of Undetermined Significance (LC-MGUS)
Azimi, V., Fiala, M. A. & Zaydman, M. A., Sep 1 2023, In: Clinical chemistry. 69, 9, p. 1084-1086 3 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Walker et al. Diversity in Clinical Trials
Thussu, S. & Fiala, M. A., Apr 2023, In: Journal of general internal medicine. 38, 5, p. 1314-1315 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
2022
A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemia
Vasu, S., Altman, J. K., Uy, G. L., Tallman, M. S., Gojo, I., Lozanski, G., Burkard, U., Osswald, A., James, P., Rüter, B. & Blum, W., Mar 2022, In: Haematologica. 107, 3, p. 770-773 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access10 Scopus citations -
Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy
Ferraro, F., Gruszczynska, A., Ruzinova, M. B., Miller, C. A., Percival, M. E., Uy, G. L., Pusic, I., Jacoby, M. A., Christopher, M. J., Kim, M. Y., Westervelt, P., Cashen, A. F., Schroeder, M. A., DiPersio, J. F., Abboud, C. N., Wartman, L. D., Gao, F., Link, D. C., Ley, T. J. & Welch, J. S., Jul 2022, In: Haematologica. 107, 7, p. 1709-1713 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access4 Scopus citations -
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies
Ghobadi, A., Landmann, J. H., Carter, A., Cooper, M. L., Selli, M. E., Chang, J., Baker, M., Miller, C. A., Ferraro, F., Chen, D. Y., Smith, A. M., LaValle, T. A., Duncavage, E. J., Chou, J., Tam, V., Benoun, J. M., Nater, J., Scholler, N., Milletti, F. & Vezan, R. & 3 others, , Oct 25 2022, In: Blood Advances. 6, 20, p. 5634-5640 7 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Increased early mortality after fludarabine and melphalan conditioning with peripheral blood grafts in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide
Eastburg, L., Russler-Germain, D. A., DiPersio, J. F., Fountaine, T., Andolina, J. R., Abboud, R. & Huselton, E., 2022, In: Leukemia and Lymphoma. 63, 1, p. 222-226 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHD
Meyers, G., Hamadani, M., Martens, M., Ali, H., Choe, H., Dawson, P., Harris, A. C., van Hooren, E., Klaassen, W., Leifer, E., MacMillan, M. L., van Oosterhout, Y., Perez, L., Pusic, I., Vo, P. & Levine, J. E., Feb 2022, In: Bone Marrow Transplantation. 57, 2, p. 302-303 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
Racial disparities in time to hematopoietic cell transplant among patients with hematologic malignancies at a large urban academic center
Shah, H., Kim, S., Klimecki, S., Charlson, K., Uberti, J., Schiffer, C. A., Fiala, M. A. & Seymour, E., Jul 2022, In: Bone Marrow Transplantation. 57, 7, p. 1213-1215 3 p.Research output: Contribution to journal › Letter › peer-review
2 Scopus citations -
Transplant outcomes after CPX-351 vs 7 1 3 in older adults with newly diagnosed high-risk and/or secondary AML
Uy, G. L., Newell, L. F., Lin, T. L., Goldberg, S. L., Wieduwilt, M. J., Ryan, R. J., Faderl, S. & Lancet, J. E., Sep 13 2022, In: Blood Advances. 6, 17, p. 4989-4993 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access9 Scopus citations -
2021
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
Mikhael, J., Belhadj-Merzoug, K., Hulin, C., Vincent, L., Moreau, P., Gasparetto, C., Pour, L., Spicka, I., Vij, R., Zonder, J., Atanackovic, D., Gabrail, N., Martin, T. G., Perrot, A., Bensfia, S., Weng, Q., Brillac, C., Semiond, D., Macé, S. & Corzo, K. P. & 1 others, , May 2021, In: Blood cancer journal. 11, 5, 89.Research output: Contribution to journal › Letter › peer-review
Open Access54 Scopus citations -
A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myeloma
Liu, L., Fiala, M., Gao, F., King, J., Goldsmith, S., Wildes, T. M., Stockerl-Goldstein, K., Vij, R. & Schroeder, M. A., 2021, In: Leukemia and Lymphoma. 62, 12, p. 3043-3046 4 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78
Fiala, M. A., King, J., Feinberg, D., Goldsmith, S. R., Schroeder, M. A., Ghobadi, A., Stockerl-Goldstein, K. E., Vij, R. & Wildes, T. M., Aug 2021, In: Bone Marrow Transplantation. 56, 8, p. 2016-2018 3 p.Research output: Contribution to journal › Letter › peer-review
2 Scopus citations -
Can planned CD34+ stem cell boost prevent poor graft function after peripheral blood haploidentical hematopoietic transplantation?
Abboud, R., Slade, M., Abboud, C. & DiPersio, J. F., 2021, In: Leukemia and Lymphoma. 62, 3, p. 749-751 3 p.Research output: Contribution to journal › Letter › peer-review
2 Scopus citations -
Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes
Garcia-Manero, G., Diez-Campelo, M., Vellenga, E., Jacoby, M. A., Merchan, B., Breems, D., Cortelezzi, A., Doronin, V., Gomez, V., Beckers, M., Della Porta, M. G., Varsos, H., Xiu, L., DeAngelis, N., Nnane, I., Rose, E. & van Eygen, K., Apr 1 2021, In: American journal of hematology. 96, 4, p. E111-E114Research output: Contribution to journal › Letter › peer-review
Open Access -
Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC)
Jacoby, M. A., Finn, L., Emadi, A., Saba, N. S., Powell, B. L., Seiter, K., Garcia, R., Faderl, S. & Male, H. J., 2021, In: Leukemia and Lymphoma. 62, 10, p. 2539-2542 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy
Spiegel, J. Y., Dahiya, S., Jain, M. D., Tamaresis, J., Nastoupil, L. J., Jacobs, M. T., Ghobadi, A., Lin, Y., Lunning, M., Lekakis, L., Reagan, P., Oluwole, O., McGuirk, J., Deol, A., Goy, A., Vu, K., Andreadis, C., Munoz, J., Bennani, N. N. & Vose, J. M. & 6 others, , Apr 1 2021, In: Blood. 137, 13, p. 1832-1835 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access83 Scopus citations -
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH
Cornell, R., Hari, P., Tang, S., Biran, N., Callander, N., Chari, A., Chhabra, S., Fiala, M. A., Gahvari, Z., Gandhi, U., Godby, K., Gupta, R., Jagannath, S., Jagosky, M., Kang, Y., Kansagra, A., Kauffman, M., Kodali, S., Kumar, S. K. & Lakshman, A. & 18 others, , Jan 2021, In: American journal of hematology. 96, 1, p. E5-E8Research output: Contribution to journal › Letter › peer-review
Open Access20 Scopus citations -
2020
Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma
Fiala, M. A., Vosuri, V., Goldsmith, S., Schroeder, M. A., Ghobadi, A., Wildes, T. M., Stockerl-Goldstein, K. E. & Vij, R., Jun 1 2020, In: Bone Marrow Transplantation. 55, 6, p. 1188-1190 3 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Reply
Barnell, E. K., Kang, Y., Wurtzler, E. M., Griffith, M., Chaudhuri, A. A. & Griffith, O. L., Feb 2020, In: Gastroenterology. 158, 3, p. 793-794 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Ruxolitinib for steroid-refractory acute graft-versus-host disease
Toama, W., Fiala, M., Pusic, I., Westervelt, P., Dipersio, J. F. & Schroeder, M., Feb 1 2020, In: Transplant International. 33, 2, p. 244-246 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Selective targeting of α4β1 integrin attenuates murine graft versus host disease
Alahmari, B., Cooper, M. L., Vij, K., Ritchey, J., Ruminski, P., Gao, F., Choi, J. & DiPersio, J. F., Nov 1 2020, In: Leukemia. 34, 11, p. 3100-3104 5 p.Research output: Contribution to journal › Letter › peer-review
7 Scopus citations -
Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia
Abboud, R., Chendamarai, E., Rettig, M. P., Trinkaus, K. M., Riedell, P. A., Abboud, C. N., Ghobadi, A., Pusic, I., Stockerl-Goldstein, K., Schroeder, M. A., Vij, R., Westervelt, P., DiPersio, J. F. & Uy, G. L., Aug 1 2020, In: Haematologica. 105, 8, p. E404-E407Research output: Contribution to journal › Letter › peer-review
Open Access13 Scopus citations -
2019
African American patients may or may not have poorer response rates after monoclonal antibody treatment: Overreliance on P values in underpowered studies
Fiala, M. A., Jul 1 2019, In: Cancer. 125, 13, p. 2321-2322 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
CCGG deletion (rs201074739) in CD33 results in premature termination codon and complete loss of CD33 expression: another key variant with potential impact on response to CD33-directed agents
Papageorgiou, I., Loken, M. R., Brodersen, L. E., Gbadamosi, M., Uy, G. L., Meshinchi, S. & Lamba, J. K., Jul 29 2019, In: Leukemia and Lymphoma. 60, 9, p. 2287-2290 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access9 Scopus citations -
Exome analysis of treatment-related AML after APL suggests secondary evolution
Wang, T., Jacoby, M. A., Duncavage, E. J., Miller, C. A., Heath, S., Rahme, R., Fenaux, P., Ades, L., Renneville, A., Cassinat, B., Takeshita, A., Asou, N., Miyazaki, Y., Kiyoi, H., Ravandi, F., Westervelt, P., Wartman, L. D. & Welch, J. S., Jun 2019, In: British Journal of Haematology. 185, 5, p. 984-987 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Immune escape of AML cells after transplantation
Christopher, M., DiPersio, J. F. & Ley, T. J., Mar 28 2019, In: New England Journal of Medicine. 380, 13, p. 1289-1290 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy
Muz, B., Azab, F., Fiala, M., King, J., Kohnen, D., Fogler, W. E., Smith, T., Magnani, J. L., Vij, R. & Azab, A. K., Sep 1 2019, In: Blood cancer journal. 9, 9, 68.Research output: Contribution to journal › Letter › peer-review
Open Access19 Scopus citations -
Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: KEYNOTE-013
Ribrag, V., Avigan, D. E., Green, D. J., Wise-Draper, T., Posada, J. G., Vij, R., Zhu, Y., Farooqui, M. Z. H., Marinello, P. & Siegel, D. S., Aug 2019, In: British Journal of Haematology. 186, 3, p. e41-e44Research output: Contribution to journal › Letter › peer-review
Open Access68 Scopus citations -
2018
Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis
Kanate, A. S., DiGilio, A., Ahn, K. W., Al Malki, M., Jacobsen, E., Steinberg, A., Hamerschlak, N., Kharfan-Dabaja, M., Salit, R., Ball, E., Bashir, Q., Cashen, A., Couriel, D., Diez-Martin, J., Katsanis, E., Linhares, Y., Mori, S., Nash, R., Pawarode, A. & Perales, M. A. & 11 others, , Sep 2018, In: British Journal of Haematology. 182, 6, p. 916-920 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access58 Scopus citations -
Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation
Turcotte, L. M., Wang, T., Hemmer, M. T., Spellman, S. R., Arora, M., Couriel, D., Alousi, A., Pidala, J., Abdel-Azim, H., Ahmed, I., Beitinjaneh, A., Buchbinder, D., Byrne, M., Callander, N., Chao, N., Choi, S. W., Defilipp, Z., Gadalla, S. M., Gale, R. P. & Gergis, U. & 25 others, , Jul 1 2018, In: Bone Marrow Transplantation. 53, 7, p. 932-937 6 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia
Walter, R. B., Michaelis, L. C., Othus, M., Uy, G. L., Radich, J. P., Little, R. F., Hita, S., Saini, L., Foran, J. M., Gerds, A. T., Klepin, H. D., Hay, A. E., Assouline, S., Lancet, J. E., Couban, S., Litzow, M. R., Stone, R. M. & Erba, H. P., Feb 2018, In: American journal of hematology. 93, 2, p. E49-E52Research output: Contribution to journal › Letter › peer-review
Open Access13 Scopus citations -
Ixazomib, an oral proteasome inhibitor, induces rapid mobilization of hematopoietic progenitor cells in mice
Ghobadi, A., Rettig, M. P., Holt, M. S., Ritchey, J. K., Kennerly, K., Chendamarai, E., Eissenberg, L. & DiPersio, J. F., Jun 7 2018, In: Blood. 131, 23, p. 2594-2596 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access4 Scopus citations